Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial  

The overall goal of this project is to conduct a therapeutic trial to assess the effect of docosahexaenoic acid (DHA) vs. placebo treatment on the global severity, behavioral symptoms, and functional ability of child and adolescent autistic disorder in a 12-week double-blind placebo-controlled parallel study. It contains three separate projects: conducting a double blind clinical trial; developing analytical assays for lipid biomarkers; genotyping GSTM1*0 and several genes related to DHA metabolism and testing whether the gene variants correlate with response to DHA treatment. Project Status
ONGOING

2009

Funder Department of Defense
Fiscal Year Funding $0.00
Project Number AS073084
Principal Investigator Johnson, William
Received ARRA Funding? No
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Interventions)
Strategic Plan Objective Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.
Federal or Private? Federal
Institution University of Medicine & Dentistry of New Jersey - Robert Wood Johnson Medical School
State/Country New Jersey
Web Link 1 Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial (External web link)
Web Link 2 No URL available.
Web Link 3 No URL available.
New! History/Related Projects Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | $0.00 | 2009 | AS073084P2
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | $0.00 | 2009 | AS073084P1
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | $0.00 | 2010 | AS073084
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | $0.00 | 2010 | AS073084P2
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | $0.00 | 2010 | AS073084P1